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DOI 10.1186/s13195-014-0080-3RESEARCH Open AccessElevated cerebrovascular resistance index is
associated with cognitive dysfunction in the
very-old
Lindsay R Clark1,7*, Daniel A Nation2, Christina E Wierenga3,4, Katherine J Bangen3, Sheena I Dev1, David D Shin5,
Lisa Delano-Wood3,4, Thomas T Liu5, Robert A Rissman6 and Mark W Bondi3,4*Abstract
Introduction: Age-related vascular changes, including blood pressure elevation and cerebral blood flow (CBF)
reduction, are associated with cognitive decline and Alzheimer’s disease (AD). Evidence suggests that the
relationship between blood pressure and dementia risk varies between younger and older samples within the
elderly population.
Methods: We examined the relationship between mean arterial pressure (MAP), CBF, and cognition in young-old
(60 to 75 years of age) versus very-old (80+ years of age) adults. Fifty-eight non-demented older adults completed
an arterial spin labeling MRI scan, and an index of cerebrovascular resistance (CVRi) was estimated for each participant
by calculating the ratio of MAP and CBF.
Results: Results demonstrated a similar negative relationship between MAP and CBF across both age groups.
However, very-old participants exhibited elevated CVRi and reduced CBF compared to young-old participants in
regions implicated in AD and cerebral small vessel disease. Furthermore, significant age by CVRi interactions revealed
that elevated CVRi in the thalamus was inversely related to verbal fluency performance in the very-old group.
Conclusions: Findings support CVRi as a potential vascular biomarker and suggest that regionally-specific vascular
changes may contribute to cognitive decline, particularly in the very-old.Introduction
Growing evidence suggests that cerebral small vessel
disease is more common and severe in adults over the
age of 80 (termed the ‘very-old’) and that elevated cere-
brovascular disease burden may lower the threshold of
Alzheimer’s disease (AD) pathology necessary to produce
clinical signs of dementia [1,2]. Additionally, studies have
reported a greater prevalence of mixed AD and vascular
pathology in the oldest-old population [3]. Thus, inves-
tigating markers of cerebrovascular disease in individuals
over the age of 80 is particularly important, as this group
is both the fastest growing segment of the population and
at highest risk for dementia [4].* Correspondence: lrclark@medicine.wisc.edu; mbondi@ucsd.edu
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unless otherwise stated.A dynamic, non-linear relationship exists between
arterial blood pressure (BP) and risk for AD and stroke
with advancing age [5]. Studies have consistently docu-
mented the association between midlife hypertension
and increased risk for AD [6]; however, the relationship
between BP and dementia in later life is less clear, with
some studies suggesting that lower BP infers greater risk
for dementia in advanced age. Furthermore, subtle
cerebrovascular dysfunction associated with BP elevation
may lead to reduced cerebral blood flow (CBF) and con-
tribute to risk for cerebrovascular disease [7]. Although
widespread reduction of CBF occurs during normal
aging [8-10], the relationship between CBF and BP may
influence the development of cerebrovascular disease
and cortical atrophy, promoting vulnerability to neuro-
degenerative disease [11].
Cerebral autoregulation serves to maintain a constant
level of global CBF (for example, typically around 50 ml/
100 g/minute) in the context of spontaneous fluctuationshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Hypothesized relationships depicting elevation in
CVRi in the very-old resulting from increased MAP and reduced
CBF. CBF, cerebral blood flow; CVRi, index of cerebrovascular
resistance; MAP, mean arterial pressure.
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logic range (for example, between 60 and 150 mmHg)
[12]. The relationship between MAP and CBF largely
defines the degree of cerebrovascular resistance in the
presence of normal intracranial pressure (ICP). Cerebro-
vascular resistance may be expressed as the ratio of
cerebral perfusion pressure (Pα) to CBF (Pα/CBF), where
Pα =MAP – ICP [13]. To maintain constant CBF,
vessels constrict during hypertension and dilate during
hypotension [14], and cerebrovascular resistance typic-
ally remains low to sustain the high blood supply
needed to the brain [15]. Recent studies indicate that
cerebral autoregulation remains relatively preserved
during normal aging and in AD at a steady state [16].
However, during aging, the lower end of the autoregula-
tory curve shifts towards higher BP, which may increase
sensitivity of the brain to hypoperfusion at lower BPs
[12,17], and cerebral autoregulation mechanisms may
be disrupted in the context of chronic hypertension and
fluctuations in BP [18,19]. Despite the well-established
association between elevated BP and reduced CBF with
age, few studies have examined the interaction between
BP and subtle, regional microvascular CBF at a steady
state in the very-old. Greater understanding of the rela-
tionship between BP, CBF and cognition in very-old
cohorts may improve identification of individuals at risk
for cognitive decline and advance the development of
treatments to slow the rate of decline.
In a recent study, we demonstrated that individuals
with AD exhibit an elevated index of cerebrovascular
resistance (CVRi) relative to non-demented older adults
[20]. In the current study, we expand on these initial
findings by examining the relationship between MAP,
CBF, CVRi and cognition in a sample of non-demented
older adults. Analyses compared young-old (ages 60 to
75) and very-old (80+) participants to identify clinically
relevant differences in MAP, CBF and CVRi between these
age groups. The aims of the current study included: 1) in-
vestigate the relationship between MAP and regional CBF
in both age groups; 2) compare regional CVRi and CBF
between the two age groups; and 3) examine if variations
in CVRi were associated with cognitive performance. We
hypothesized that there would be a negative relationship
between MAP and CBF in both groups (for example,
higher MAP associated with lower CBF), but that this rela-
tionship would be more pronounced in the very-old group
due to typical increases in MAP and reductions in CBF
with advancing age. Reflecting the expected higher MAP
and lower CBF in the very-old, we hypothesized that the
very-old group would, in turn, exhibit elevated CVRi com-
pared to the young-old group (see Figure 1). Furthermore,
we hypothesized that elevated CVRi would be associated
with poorer cognitive performance, particularly within
memory and executive functioning domains.Methods
Participants
Participants were non-demented older adults participating
in a longitudinal study of aging at the University of
California, San Diego (UCSD) and the VA San Diego
Healthcare System. All participants were independently
functioning older adults recruited into the aging study
from the San Diego, CA community via newspaper adver-
tisements and flyers placed in senior centers targeting
individuals who were either healthy, normally aging older
adults or who were at-risk for developing AD. Participants
were also recruited into the aging study from the UCSD
Alzheimer’s Disease Research Center. A total of 58 partici-
pants were included in the current study. Thirty-eight of
the participants were classified as young-old (between 60
and 75 years of age) and 20 participants were classified as
very-old (80 years of age or older). The young-old and
very-old groups were similar in terms of gender distribu-
tion and years of education. Exclusion criteria for the
study included a current diagnosis of dementia, current or
history of other major neurological disorders, such as
Parkinson’s disease or stroke, history of a head injury
involving a loss of consciousness, current or history of a
serious mental illness or alcohol/substance abuse, and a
pacemaker or other magnetic resonance imaging (MRI)
contraindications. The study was approved by the institu-
tional review boards at UCSD and the VA San Diego
Healthcare System, and written informed consent was
obtained from all participants.
Data acquisition
MRI data were acquired on a GE Signa HDx 3-T whole
body MR scanner using an 8-channel receive-only head
Clark et al. Alzheimer's Research & Therapy  (2015) 7:3 Page 3 of 9coil. Structural images were acquired with high-resolution
T1-weighted scans using a three-dimensional FSPGR
sequence (25 cm FOV, 256 × 192 matrix TR = 7.8 msec,
TE = min full, flip angle = 8°, inversion time = 600 ms,
bandwidth = 31.25 kHz, and 172 1 mm sagittal slices;
n = 49) or MP-RAGE sequence (identical parameters to
FSPGR except 26 cm FOV, 256 × 256 matrix, TR =
7 msec, inversion time = 900 msec, 170 1.2 mm sagittal
slices; n = 9). For a subset of 35 participants (13 very-
old, 22 young-old), T2-weighted fluid attenuated inver-
sion recovery (FLAIR) images were also acquired
(20 cm FOV, 320 × 224 matrix, flip angle = 90°, TE =
124 ms, TR = 8,500 ms, 4 mm axial slices with no inter-
slice gap).
Resting CBF images were acquired using pulsed arterial
spin labeling (ASL) with a modified flow-sensitive alternat-
ing inversion recovery sequence [21] (post-saturation and
inversion times of TI1 = 600 msec and TI2 = 1,600 msec,
TR = 2.5 sec, TE =minimum, FOV= 22 × 22 cm, 64 × 64
matrix, 20 5 mm axial slices, 40 volumes (20 tag + control
image pairs)). This sequence utilized presaturation pulses
and QUIPSS 2 post-inversion saturating pulses and a
spiral readout with four interleaves [22]. Additionally, a
scan with the inversion pulses turned off was acquired to
obtain an estimate of the magnetization of cerebrospinal
fluid (CSF). The CSF signal was used to estimate the
equilibrium magnetization of blood, which in turn was
used to convert the perfusion signal into calibrated CBF
units (ml/100 g/minute) [23]. A minimum contrast scan
was also acquired to adjust for coil inhomogeneities
during the CBF quantification step [24]. Each ASL data-
set was reconstructed using the SENSE algorithm [25].
The ASL time series was co-registered to the middle
time-point to minimize effects of participant motion. A
mean ASL image was formed for each participant from
the average difference of control and tag images using
surround subtraction, and slice timing delays were
accounted for to ensure the inversion time (TI2) was
slice specific [26].
Two brachial artery BP recordings were obtained from
each arm using an automated BP cuff while the partici-
pant was in a sitting position, and an average pressure
from the two recordings was used. MAP was calculated
using the following formula: diastolic BP + (pulse pres-
sure/3), and pulse pressure (PP) was calculated by sub-
tracting diastolic BP from systolic BP. APOE genotype
was determined using a polymerase chain reaction-based
method [10].
Memory functioning was assessed with the California
Verbal Learning Test – 2nd Edition (CVLT-II) [27] Long-
Delay Free Recall z-score, executive functioning was
measured with the Delis-Kaplan Executive Function
System (D-KEFS) [28] Trail Making Test (Number-
Letter Switching) scaled score, and language functioningwas assessed with the D-KEFS Verbal Fluency (Letter
Fluency) scaled score.
Data processing
Data were processed using Analysis of Functional
NeuroImages (AFNI; afni.nimh.nih.gov), FMRIB Software
Library (FSL, Oxford, UK), and locally created Matlab
scripts (The Mathworks Inc., Natick, MA, USA, 2010).
Skull-stripping was completed using Brain Surface
Extractor with manual editing to remove residual non-
brain material [29] and images were segmented into
gray matter (GM), white matter (WM) and CSF using
FMRIB’s Automated Segmentation Tool. The high-
resolution T1-weighted images were registered to ASL
space and the partial volume segmentations were regis-
tered and down-sampled to the ASL data resolution.
For quantification of white matter lesion (WML) volume,
a semiautomated volumetric approach was applied to T2
FLAIR images using a previously described method that
has been shown to be reliable [30]. Briefly, WMLs were
manually traced in 17 to 21 image slices in the axial plane
using AFNI. Total WML volume was quantified as the
total voxel counts (mm3). Specific data processing pro-
cedures for ASL images have been previously reported
[20]. Briefly, ASL data were converted to absolute units
of CBF, corrected for partial volume effects [31], spatially
smoothed using a 4.0 mm full-width, half-maximum
Gaussian filter, normalized to Talairach space [32],
re-sampled to a 4 × 4 × 4 mm resolution grid, and
masked to include only supratentorial gray matter CBF.
CVRi was calculated by dividing MAP by CBF in each
voxel (MAP/CBF). Secondary analyses were conducted
using PP instead of MAP (PP/CBF). A priori regions
of interest (ROIs) included two subcortical (caudate,
thalamus) and two cortical (medial temporal lobe (MTL),
posteromedial) regions defined using the Talairach atlas in
AFNI. These regions of interest were chosen based on
vulnerabilities to small vessel disease (subcortical) and
AD pathology (cortical).
Statistical analyses
All statistical tests used a significance cutoff of P < .05.
All analyses were a priori unless specified as post-hoc
analyses. Voxelwise analyses were conducted using AFNI
software and all other analyses were conducted within
SPSS software version 21.
Demographic and clinical analyses
Independent samples t-tests (continuous variables) or
chi-square (dichotomous variables) analyses compared
age groups on demographic and clinical variables.
Mann–Whitney U and Spearman correlational analyses
were used to examine WML volumes due to non-
normal distribution of the data.
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ROI analyses
Pearson bivariate correlations were conducted to exam-
ine relationships among age, MAP and mean CBF within
each of the four ROIs.
Voxelwise analyses
Voxelwise regression analyses examined the relationship
between MAP and CBF across the whole brain. Type I
error associated with multiple comparisons in voxelwise
analyses was controlled based on Monte Carlo simula-
tion results using AFNI’s AlphaSim program set with an
individual voxel alpha of 0.05. Based on an averaged GM
mask created from all participants, a minimum cluster
volume threshold of 1,344 mm3 or 21 contiguous voxels
was chosen and this threshold/volume combination
protected a whole-brain probability of false positives of
P < .05. Mean CBF values were extracted from signifi-
cant clusters resulting from the voxelwise regression
analysis, and these CBF values were included in post-hoc
exploratory multiple linear regression models using a
significance cutoff of P < .05. These post-hoc regression
models included age group, MAP and an age group ×
MAP interaction term as predictor variables and mean
CBF within each cluster as the outcome variable.
Between-group differences in CBF and CVRi
Voxelwise two-tailed t-test analyses compared the young-
old and very-old groups on whole brain CVRi and CBF.
Additional t-test analyses also compared the two age
groups on PP/CBF. Correction for multiple compari-
sons was completed using the procedure described
above that protected a whole-brain probability of false
positives of P < .05.
Relationship between CVRi and cognition
Hierarchical multiple linear regression analyses tested
hypothesized interaction effects between age group and
CVRi within each ROI on measures of memory, execu-
tive functioning and language. Each model included
gender and education as covariates in the first block,
the main effects of age group and CVRi in the second
block, and the interaction of age group and CVRi in the
third block. Standardized scores on each cognitive
measure were used as outcome variables.
Results
Demographic and clinical characteristics
The young-old and very-old groups did not differ in gen-
der distribution (P = .55), years of education completed
(P = .69) or distribution of APOE ε4 carriers (P = .39)
(see Table 1). The very-old group exhibited significantly
elevated PP (P < .05) compared to the young-old group,
but the groups did not significantly differ on MAP(P = .06). Additionally, the very-old group did not signifi-
cantly differ from the young-old group in anti-hypertensive
medication use (P = .07). The two age groups also demon-
strated similar performances on the three neuropsycho-
logical measures included in this study (Ps > .42). Table 1
displays the means and standard deviations of the demo-
graphic and clinical variables for each age group.
Relationships among age, mean arterial pressure and
cerebral blood flow
Across the total sample, age was positively correlated
with MAP (r = .33, P = .01). There was a negative rela-
tionship between age and CBF in the thalamus (r = −.24,
P < .05), but non-significant correlations between age
and CBF in the remaining ROIs (Ps > .20). MAP was not
correlated with mean global CBF (r = −.13; P = .34).
Voxelwise regression analyses revealed negative rela-
tionships between MAP and regional CBF in posterior
regions (posterior cingulate, precuneus, cuneus, fusiform
gyrus), subcortical regions (thalamus, lentiform nucleus)
and inferior frontal gyrus across the total sample.
Exploratory post-hoc analyses examined whether the
relationship between MAP and CBF from within each
significant cluster differed between the young-old and
very-old groups. Figure 2 displays the mean CBF values for
each age group within each significant cluster. These post-
hoc analyses revealed significant main effects of MAP in
the five posterior clusters (all Ps < .05), indicating a nega-
tive relationship between MAP and CBF across both age
groups. A significant interaction effect between age group
and MAP on CBF was observed in the thalamus (P < .05).
Simple effects analyses revealed that MAP accounted for
a significant amount of variance in thalamus CBF in
the young-old group (β = −2.47; P < .001), but was non-
significant in the very-old group (β = −.78; P = .17).
CVRi differences between age groups across the whole
brain
Voxelwise t-test analyses resulted in two significant clus-
ters in the parahippocampal gyrus/caudate and cuneus/
lingual gyrus in which the very-old group exhibited
significantly elevated CVRi compared to the young-old
group (see Table 2). Reduced CBF in the very-old group
relative to the young-old group was exhibited in the
caudate, medial frontal gyrus, and precuneus. Post-hoc
analyses demonstrated PP/CBF elevations in the very-old
group in similar regions as CVRi, as well as additional
anterior regions, parietal regions, middle temporal
gyrus and thalamus. Group differences in CVRi, PP/
CBF and CBF are displayed in Figure 3.
Relationships between regional CVRi and total WML volume
Mann Whitney U tests revealed that the very-old group ex-
hibited greater total WML volume (P= .001), periventricular
Table 1 Demographic and clinical characteristics of young-old and very-old groups
Young-old (60 to 75) Very-old (80+) P
Number 38 20
Age (years) 69.1 (3.9) 84.8 (4.0) <.001
Gender (M/F) (number) 14/24 9/11 .55
Education (years) 15.9 (1.9) 15.7 (3.0) .69
APOE (ε4-negative/ε4-positive) (number) 21/15 14/6 .39
Systolic BP 125.8 (14.2) 136.2 (17.8) <.05
Diastolic BP 74.9 (7.7) 77.8 (11.7) .26
Mean arterial pressure 91.9 (8.6) 97.3 (13.0) .06
Pulse pressure 50.9 (12.4) 58.4 (11.3) <.05
Anti-hyperintensive medication use (number currently prescribed
medication/number not currently prescribed medication)
17/21 14/6 .07
CVLT-II Long delay free recall z-score 0.3 0.6 .42
D-KEFS Verbal fluency (letter) ss 12.4 13.2 .46
D-KEFS Trail making test switching ss 12.3 12.1 .82
Means (standard deviations); BP, blood pressure; CVLT-II, California Verbal Learning Test – 2nd Edition; D-KEFS, Delis-Kaplan Executive Function System; M/F,
male/female; ss, scaled score.
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compared to the young-old group. Additionally, there
was a positive association between periventricular WML
volume and CVRi in the caudate (rs = .35; P < .05).
Interaction between age group and CVRi on cognitive
performance
Hierarchical linear regression analyses resulted in a
significant interaction effect between age group andFigure 2 Mean CBF for young-old (black) and very-old (striped) groups w
regression of MAP on CBF and survived the cluster threshold alpha-protect
to maximum intensity values within each cluster (L = left, R = right, A = ante
MAP, mean arterial pressure.thalamus CVRi on language (verbal fluency) performance
(ΔR2 = .06, t = −2.03, P < .05). Follow-up simple main
effects analyses demonstrated a negative relationship
between thalamus CVRi and verbal fluency performance
in the very-old group, whereas there was a positive
relationship between CVRi and verbal fluency per-
formance in the young-old group. Additionally, there was
a non-significant trend towards an interaction between
age group and MTL CVRi on memory (word recall)ithin each significant cluster. Clusters shown resulted from voxelwise
ion procedure (P < .05, volume >1,344 mm3). Coordinates (x, y, z) refer
rior, P = posterior, S = superior, I = inferior). CBF, cerebral blood flow;
Table 2 Significant clusters resulting from voxelwise t-tests comparing CVRi and CBF between young-old and very-old
groups
Region Volume (mm3) Maximum intensity (x, y, z) Maximum intensity t
CVRi
(1) L/R Cuneus/lingual gyrus 3136 6 L, 69P, −8I 2.46
(2) R Paraphippocampal gyrus/superior temporal gyrus/caudate 1536 −42R, 41P, −20I 2.08
CBF
(1) L Caudate/lentiform nucleus 1600 14 L, 1P, 8S −2.38
(2) L/R Posterior cingulate, L/R cuneus, L precuneus 1280 −6R, 61P, 8S −2.57
(3) L/R Medial frontal gyrus 1280 2 L, −43A, 24S −3.04
PP/CBF
(1) L/R Lingual gyrus/cuneus 3136 14 L 69P -12I 2.05
(2) R Insula/inferior frontal gyrus 2816 −42R 5P -8I 4.66
(3) R Middle frontal gyrus/R superior frontal gyrus 2112 −34R -23A 32S 2.94
(4) R Inferior parietal lobule/supramarginal gyrus 1920 −58R 29P 32S 2.60
(5) R Superior frontal gyrus/R middle frontal gyrus 1664 −26R -55A 0 2.37
(6) R Middle temporal gyrus 1664 −42R 49P 8S 2.42
(7) R Thalamus/caudate/cingulate gyrus 1472 −14R 5P 12S 2.00
(8) R Fusiform gyrus/paraphippcampal gyrus/caudate 1344 −42R 41P -20S 2.41
(9) L Middle frontal gyrus 1280 22 L -31A 36S 2.28
Clusters shown survived our cluster threshold alpha-protection procedure (P < .05, volume >1,280 mm3). A, anterior; CBF, cerebral blood flow: CVRi, index of
cerebrovascular resistance; I, inferior; L, left; P, posterior; R, right; PP, pulse pressure; S, superior.
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ple main effects analyses depicted a negative relationship
between memory function and CVRi in the MTL in the
very-old group, but a positive relationship in the young-
old group. Figure 4 displays mean performance on verbalFigure 3 Significant clusters of reduced CBF and elevated CVRi and P
corrected P < .05. CBF, cerebral blood flow; CVRi, cerebrovascular resistancefluency and verbal memory measures for those with lower
than average CVRi and higher than average CVRi within
each age group. There were no significant interaction
effects between age and CVRi on executive functioning
(for example, set-shifting).P/CBF indices in the very-old group. Significant differences at
index; PP/CBF, ratio of pulse pressure to cerebral blood flow.
Figure 4 Mean cognitive scores for participants with above average (black) and below average (gray) CVRi. CVRi, index of cerebrovascular
resistance; ss, scaled score; CVLT-II California Verbal Learning Test – 2nd Edition; D-KEFS, Delis-Kaplan Executive Function System.
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This study investigated the relationship between MAP
and CBF in older adults of varying ages. In a sample of
non-demented older adults, higher MAP was associated
with reduced CBF in subcortical regions, posterior
cortical regions and inferior frontal gyrus. This negative
relationship was similar in young-old (ages 60 to 75) and
very-old groups (age 80+) suggesting that functions
of the microvasculature within these regions may be
vulnerable to elevated BP effects in older adults across
the aging spectrum. For example, higher baseline systolic
and diastolic BP in older adults has been reported to be
significantly associated with reduced total CBF over a
four year follow-up period [33]. The relationship be-
tween MAP and our measure of regional microvascular
CBF (ASL-MRI) was observed despite the lack of a
significant correlation between MAP and global CBF,
suggesting that global or large vessel CBF measures
may be less sensitive to subtle or regionally specific
cerebrovascular dysfunction associated with age-related
BP elevation.
Despite a similar relationship between MAP and CBF
across age groups, the very-old group exhibited elevated
CVRi in the caudate, parahippocampal gyrus and cuneus.
An alternate estimate of CVRi using pulse pressure rather
than mean arterial pressure (PP/CBF) also exhibited
elevations in the very-old group in similar regions as
our original CVRi estimate, as well as in additional
anterior, parietal and temporal regions. The greater
number of regions implicated with the use of PP com-
pared to MAP in our CVRi estimate may be due to the
larger elevation in PP versus MAP observed in our
sample. Elevated CVRis have previously been reported
in individuals with AD and mild cognitive impairment
[14,20], and our current findings suggest that regional
cerebrovascular resistance elevations also occur in
advanced age. The particular regions that demonstrated
CVRi elevations in the very-old have been shown to bevulnerable to cerebral small vessel disease (for example,
caudate) or neurodegeneration in early stages of AD
(for example, parahippocampal gyrus, cuneus).
Moreover, prior studies have implicated the role of
cerebral hemodynamic dysfunction in elevated WM
disease [34]. Similar to previous studies, the very-old
group exhibited greater WML burden compared to
their younger counterparts [35]. Furthermore, elevated
CVRi in the caudate, a subcortical region sensitive to
small vessel disease due to perfusion by small terminal
arteries with little collateral flow [36], was associated
with greater WML volume. Evidence suggests that
elevated BP, as well as fluctuating BP over time, is associ-
ated with elevated WML burden [19], and that reduced
CBF occurs in regions with WML [37]. Therefore, ele-
vated subcortical CVRi may be a potential marker for
age-related cerebrovascular dysfunction associated with
cerebral small vessel disease.
Furthermore, elevated thalamic CVRi was associated
with poorer verbal fluency performance within the
very-old group, whereas CVRi was not associated with
cognition in the young-old group. A similar, though
non-significant (P = .06) pattern was observed between
elevated MTL CVRi and poorer verbal memory per-
formance in the very-old group. These results suggest
that elevated BP in the context of reduced CBF may
have a more detrimental impact on cognitive function-
ing in advanced age and has regionally specific effects
on cognitive abilities subsumed by those regions.
Further studies are needed to investigate the etiology
of elevated cerebrovascular resistance in the very-old. One
hypothesis of elevated cerebrovascular resistance in older
adults with AD that has been proposed is vasoconstriction
associated with increased amyloidosis [14]. Although
the participants in this study were non-demented, it
is possible that elevated cerebrovascular resistance in
the very-old may also reflect underlying amyloidosis,
consistent with greater Alzheimer’s pathology often
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animal studies demonstrate that aged hypertensive mice
exhibit cerebral autoregulatory dysfunction, and that
this dysfunction is associated with cerebromicrovascular
damage, including disruption of the blood–brain barrier
and neuroinflammation [19]. It is possible that elevated
CVRi in the very-old may reflect capillary dysfunction that
contributes to neurovascular dysfunction and increases
risk for development of AD pathology and cognitive
decline [38]; however, these hypotheses will need to be
investigated further in future studies.
There are several limitations of the current study that
should be considered. First, our sample size was rela-
tively small, particularly that of the very-old group, and
it will be important to validate the current findings and
explore the relationship between BP and CBF in a larger
sample of very-old participants in the future. Addition-
ally, our measure of arterial BP was conducted outside
of the MRI scanner, rather than concurrently acquired with
the CBF data. Future studies using an MRI-compatible BP
monitor may be able to calculate a more direct index of
regional cerebrovascular resistance within particular
structures, which may be more sensitive to these age-
related changes in pressure-flow relationships within
the brain. Additionally, several analyses were conducted
in this study and, although we corrected for multiple
comparisons in our voxelwise analyses, it is possible
that some of our findings may be inflated due to Type I
error. As noted above, additional follow-up studies to
explore and validate these findings in separate samples
will be needed to confirm the accuracy of these results.
Additionally, due to the cross-sectional nature of the
study we are unable to determine causal relationships
between elevated CVRi and its regional associations
with cognitive function. However, these participants will
continue to be followed annually and future studies will
provide information regarding cognitive change in these
individuals. Longitudinal follow-up studies with neuro-
pathologic data will also be helpful in validating the
relationship between CVRi elevations and occult cere-
brovascular disease at autopsy. Lastly, although the
young-old and very-old participants in this study had
similar patterns of anti-hypertensive medication use,
we did not have access to detailed information regard-
ing the duration of medication use within our two
groups. Further investigation of the contribution of
anti-hypertensive medication use on CBF and CVRi in the
very-old will be important to assess in future studies.
Conclusions
Our study provides evidence that an index of cerebro-
vascular resistance is elevated in a non-demented very-
old group within regions associated with AD and small
vessel disease, and that elevated CVRi is associated withregionally specific effects on cognitive abilities subsumed
by those regions in the very-old. Our results suggest that
continued investigation of CVRi may be warranted as it
may represent a useful marker for occult cerebrovascular
disease related to vascular aging. Previous studies indi-
cate that cognitive and morphometric changes in very-
old AD patients are less salient than those in young-old
patients; therefore, additional markers may be needed to
enhance the ability to detect early AD in individuals at
the upper end of the age spectrum [39].
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